Tonix Pharmaceuticals Holding Corp. (TNXP)
3.01
-0.23
(-7.10%)
USD |
NASDAQ |
Nov 13, 16:00
3.06
+0.05
(+1.66%)
After-Hours: 19:59
Tonix Pharmaceuticals Price : 3.01 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 3.96 | 3.96 | 3.21 | 3.24 | 2.455M |
| Nov 11, 2026 | 4.16 | 4.17 | 3.82 | 3.87 | 3.176M |
| Nov 10, 2026 | 4.51 | 4.60 | 4.07 | 4.10 | 1.014M |
| Nov 09, 2026 | 4.105 | 5.009 | 4.00 | 4.49 | 1.450M |
| Nov 06, 2026 | 4.68 | 4.83 | 4.63 | 4.74 | 741820.0 |
| Nov 05, 2026 | 5.10 | 5.10 | 4.55 | 4.60 | 1.209M |
| Nov 04, 2026 | 5.28 | 5.38 | 5.085 | 5.11 | 413859.0 |
| Nov 03, 2026 | 5.16 | 5.39 | 5.16 | 5.19 | 489359.0 |
| Nov 02, 2026 | 5.10 | 5.22 | 5.04 | 5.15 | 622508.0 |
| Oct 30, 2026 | 5.18 | 5.29 | 4.96 | 5.10 | 567188.0 |
| Oct 29, 2026 | 5.45 | 5.51 | 5.202 | 5.28 | 619573.0 |
| Oct 28, 2026 | 5.40 | 5.40 | 5.09 | 5.37 | 573971.0 |
| Oct 27, 2026 | 5.32 | 5.49 | 5.22 | 5.39 | 955245.0 |
| Oct 26, 2026 | 5.42 | 5.51 | 5.13 | 5.30 | 667490.0 |
| Oct 23, 2026 | 5.09 | 5.20 | 5.01 | 5.17 | 754751.0 |
| Oct 22, 2026 | 5.37 | 5.46 | 5.05 | 5.13 | 905741.0 |
| Oct 21, 2026 | 5.85 | 6.04 | 5.395 | 5.43 | 874998.0 |
| Oct 20, 2026 | 5.73 | 6.04 | 5.545 | 5.78 | 752386.0 |
| Oct 19, 2026 | 6.10 | 6.22 | 5.61 | 5.73 | 1.338M |
| Oct 16, 2026 | 6.46 | 6.56 | 6.02 | 6.04 | 935464.0 |
| Oct 15, 2026 | 6.50 | 6.69 | 6.28 | 6.42 | 2.399M |
| Oct 14, 2026 | 6.03 | 6.72 | 6.01 | 6.40 | 1.388M |
| Oct 13, 2026 | 6.61 | 6.680 | 6.11 | 6.13 | 1.139M |
| Oct 12, 2026 | 7.24 | 7.28 | 6.635 | 6.64 | 960512.0 |
| Oct 09, 2026 | 7.27 | 7.54 | 7.09 | 7.30 | 963564.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Heron Therapeutics, Inc. | 0.3111 |
| Inovio Pharmaceuticals, Inc. | 1.435 |
| Nektar Therapeutics | 37.27 |
| Karyopharm Therapeutics, Inc. | 0.0255 |
| Minerva Neurosciences, Inc. | 2.30 |
Price Related Metrics
| PS Ratio | 1.059 |
| Price to Book Value | 0.2889 |
| Earnings Yield | -406.6% |
| Market Cap | 57.64M |